DISSOLVING
MICRONEEDLE
PLATFORM
University Medical is in pre-clinical development of stable, painless and simple vaccine and drug delivery via novel, dissolving Microneedle arrays.
Microneedle arrays use our skin's own highly evolved and efficient immune response, making transdermal delivery as good or better than intramuscular injection.
MICRONEEDLE ADVANTAGES
• Thermostable
• 10-15 minute
painless
dissolve time
• Self-application
potential
LAB PROTOTYPE
MICRONEEDLE ARRAY
PATCH SHOWN
• Dose sparing opportunity with highly customizable arrays and loading
• Novel and scalable
manufacturing
ELIMINATE COLD CHAIN
NO SHARPS DISPOSAL
RECONSTITUTION NOT REQUIRED
pandemic reach and readiness
Faster pandemic response with increased vaccination coverage into developing countries.
SCIENTIFIC COLLABORATORS
UC Irvine Institute for Immunology
UNCW Dept. of Chemistry and Biochemistry
Queens University Belfast
SRI International Biosciences Division
TriLink BioTechnologies
PROOF OF CONCEPT
We have completed proof-of-concept validation in a collaborative university study, and are currently conducting immunogenicity studies with our Dissolving Microneedle Array Technology (DMAT).
